LexisNexis acquires IPlytics & more…Keep up with what has been happening this week in our latest IP news round-up…

Moving Toward a Design Patent Bar – Progress in the IP Community

IP Watchdog looks into the changes happening to patents in the US and how that will challenge the IP community.

RWS appoints Daniel Bennett as President of IP Services Division

RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, announces the appointment of Daniel Bennett as President of its IP Services Division and as a member of the Executive Team. Daniel will be responsible for the Group’s full suite of innovation lifecycle management services, including patent translation and filing, renewals and IP research studies.

LexisNexis expands its Intellectual Property Solutions suite with the acquisition of IPlytics

LexisNexis® Legal & Professional, part of RELX, announced that it has acquired IPlytics, a leading IP intelligence company that enables the analysis of technology landscapes and competition for industries where standards and patents matter by providing access to multiple databases connecting patents, Standard Essential Patents (SEPs), standards, and technical standards contributions. The acquisition extends the vision of LexisNexis Intellectual Property Solutions to bring clarity to innovation and help companies worldwide to be more effective at bringing meaningful innovations into the world.

Eli Lilly ordered to pay $176.5 mln to Teva in U.S. migraine drug patent trial

Eli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three Teva patents, a Boston federal court jury decided on Wednesday.